{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:30:46Z","timestamp":1720747846247},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T00:00:00Z","timestamp":1294876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00417-010-1608-2","type":"journal-article","created":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T13:30:37Z","timestamp":1294839037000},"page":"849-857","source":"Crossref","is-referenced-by-count":20,"title":["Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline"],"prefix":"10.1007","volume":"249","author":[{"given":"Hani","family":"Levkovitch-Verbin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriel","family":"Spierer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Vander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Dardik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,13]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1167\/iovs.05-0996","volume":"47","author":"H Levkovitch-Verbin","year":"2006","unstructured":"Levkovitch-Verbin H, Dardik R, Vander S, Nisgav Y, Kalev-Landoy M, Melamed S (2006) Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes. Invest Ophthalmol Vis Sci 47:2491\u20132497","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR2","first-page":"402","volume":"43","author":"H Levkovitch-Verbin","year":"2002","unstructured":"Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME (2002) Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci 43:402\u2013410","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1608_CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.exer.2009.11.014","volume":"19","author":"H Levkovitch-Verbin","year":"2010","unstructured":"Levkovitch-Verbin H, Dardik R, Vander S, Melamed S (2010) Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve. Exp Eye Res 91(2):127\u2013134","journal-title":"Exp Eye Res"},{"key":"1608_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1371\/journal.pgen.0010017","volume":"1","author":"RT Libby","year":"2005","unstructured":"Libby RT, Li Y, Savinova OV, Barter J, Smith RS, Nickells RW, John SW (2005) Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 1:17\u201326","journal-title":"PLoS Genet"},{"key":"1608_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0079-6123(08)01129-1","volume":"173","author":"RW Nickells","year":"2008","unstructured":"Nickells RW, Semaan SJ, Schlamp CL (2008) Involvement of the Bcl2 gene family in the signaling and control of retinal ganglion cell death. Prog Brain Res 173:423\u2013435","journal-title":"Prog Brain Res"},{"key":"1608_CR6","first-page":"975","volume":"42","author":"H Levkovitch-Verbin","year":"2001","unstructured":"Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA, D'Anna SA, Kerrigan D, Pease ME (2001) Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci 42:975\u2013982","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR7","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1167\/iovs.02-0646","volume":"44","author":"H Levkovitch-Verbin","year":"2003","unstructured":"Levkovitch-Verbin H, Quigley HA, Martin KR, Zack DJ, Pease ME, Valenta DF (2003) A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest Ophthalmol Vis Sci 44:3388\u20133393","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.cr.7290046","volume":"10","author":"YL Yang","year":"2000","unstructured":"Yang YL, Li XM (2000) The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res 10:169\u2013177","journal-title":"Cell Res"},{"key":"1608_CR9","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1167\/iovs.07-0542","volume":"48","author":"Z Yang","year":"2007","unstructured":"Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, Valenta D, Zack DJ (2007) Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci 48:5539\u20135548","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1128\/MCB.19.3.1673","volume":"19","author":"F Carrier","year":"1999","unstructured":"Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, Weinstein JN, Pommier Y, Fornace AJ Jr (1999) Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol Cell Biol 19:1673\u20131685","journal-title":"Mol Cell Biol"},{"key":"1608_CR11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/MCB.20.1.233-241.2000","volume":"20","author":"Z Gu","year":"2000","unstructured":"Gu Z, Flemington C, Chittenden T, Zambetti GP (2000) ei24, a p53 response gene involved in growth suppression and apoptosis. Mol Cell Biol 20:233\u2013241","journal-title":"Mol Cell Biol"},{"key":"1608_CR12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1523\/JNEUROSCI.23-04-01237.2003","volume":"23","author":"HJ Rideout","year":"2003","unstructured":"Rideout HJ, Wang Q, Park DS, Stefanis L (2003) Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition. J Neurosci 23:1237\u20131245","journal-title":"J Neurosci"},{"key":"1608_CR13","first-page":"1787","volume":"42","author":"G Tezel","year":"2001","unstructured":"Tezel G, Li LY, Patil RV, Wax MB (2001) TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 42:1787\u20131794","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR14","doi-asserted-by":"crossref","first-page":"8693","DOI":"10.1523\/JNEUROSCI.20-23-08693.2000","volume":"20","author":"G Tezel","year":"2000","unstructured":"Tezel G, Wax MB (2000) Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 20:8693\u20138700","journal-title":"J Neurosci"},{"key":"1608_CR15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1006\/exer.2001.1072","volume":"73","author":"S Yoneda","year":"2001","unstructured":"Yoneda S, Tanihara H, Kido N, Honda Y, Goto W, Hara H, Miyawaki N (2001) Interleukin-1beta mediates ischemic injury in the rat retina. Exp Eye Res 73:661\u2013667","journal-title":"Exp Eye Res"},{"key":"1608_CR16","doi-asserted-by":"crossref","first-page":"31240","DOI":"10.1074\/jbc.M502641200","volume":"280","author":"X Zhou","year":"2005","unstructured":"Zhou X, Li F, Kong L, Tomita H, Li C, Cao W (2005) Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. J Biol Chem 280:31240\u201331248","journal-title":"J Biol Chem"},{"key":"1608_CR17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1592\/phco.26.4.515","volume":"26","author":"HF Elewa","year":"2006","unstructured":"Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC (2006) Minocycline for short-term neuroprotection. Pharmacotherapy 26:515\u2013521","journal-title":"Pharmacotherapy"},{"issue":"2","key":"1608_CR18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","volume":"71","author":"Y Levkovitz","year":"2010","unstructured":"Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, Fennig S, Treves I, Kron S (2010) A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 71(2):138\u2013149","journal-title":"J Clin Psychiatry"},{"key":"1608_CR19","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","volume":"69","author":"Y Lampl","year":"2007","unstructured":"Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, Anca-Hershkowitz M, Sadeh M (2007) Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69:1404\u20131410","journal-title":"Neurology"},{"key":"1608_CR20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.124.4.520","volume":"124","author":"H Levkovitch-Verbin","year":"2006","unstructured":"Levkovitch-Verbin H, Kalev-Landoy M, Habot-Wilner Z, Melamed S (2006) Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection. Arch Ophthalmol 124:520\u2013526","journal-title":"Arch Ophthalmol"},{"key":"1608_CR21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuroscience.2005.04.011","volume":"134","author":"DC Baptiste","year":"2005","unstructured":"Baptiste DC, Powell KJ, Jollimore CA, Hamilton C, LeVatte TL, Archibald ML, Chauhan BC, Robertson GS, Kelly ME (2005) Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience 134:575\u2013582","journal-title":"Neuroscience"},{"key":"1608_CR22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jnen\/62.4.329","volume":"62","author":"I Ferrer","year":"2003","unstructured":"Ferrer I, Planas AM (2003) Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J Neuropathol Exp Neurol 62:329\u2013339","journal-title":"J Neuropathol Exp Neurol"},{"key":"1608_CR23","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1523\/JNEUROSCI.5643-07.2008","volume":"28","author":"V Kaushal","year":"2008","unstructured":"Kaushal V, Schlichter LC (2008) Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci 28:2221\u20132230","journal-title":"J Neurosci"},{"key":"1608_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(95)00414-9","volume":"71","author":"M Buttini","year":"1996","unstructured":"Buttini M, Appel K, Sauter A, Gebicke-Haerter PJ, Boddeke HW (1996) Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 71:1\u201316","journal-title":"Neuroscience"},{"key":"1608_CR25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.cdd.4400882","volume":"8","author":"A Martin-Villalba","year":"2001","unstructured":"Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH (2001) Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 8:679\u2013686","journal-title":"Cell Death Differ"},{"key":"1608_CR26","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.STR.25.7.1481","volume":"25","author":"T Liu","year":"1994","unstructured":"Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25:1481\u20131488","journal-title":"Stroke"},{"key":"1608_CR27","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1523\/JNEUROSCI.19-10-03809.1999","volume":"19","author":"A Martin-Villalba","year":"1999","unstructured":"Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM (1999) CD95 ligand (Fas-L\/APO-1\u00a0L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 19:3809\u20133817","journal-title":"J Neurosci"},{"key":"1608_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2006.09.022","volume":"1122","author":"KR Ju","year":"2006","unstructured":"Ju KR, Kim HS, Kim JH, Lee NY, Park CK (2006) Retinal glial cell responses and Fas\/FasL activation in rats with chronic ocular hypertension. Brain Res 1122:209\u2013221","journal-title":"Brain Res"},{"key":"1608_CR29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2003.10.029","volume":"996","author":"G Tezel","year":"2004","unstructured":"Tezel G, Yang X, Yang J, Wax MB (2004) Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Res 996:202\u2013212","journal-title":"Brain Res"},{"key":"1608_CR30","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","volume":"95","author":"J Yrjanheikki","year":"1998","unstructured":"Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 95:15769\u201315774","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1608_CR31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1017\/S0317167100008611","volume":"35","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Metz LM, Yong VW, Bell RB, Yeung M, Patry DG, Mitchell JR (2008) Pilot study of minocycline in relapsing-remitting multiple sclerosis. Can J Neurol Sci 35:185\u2013191","journal-title":"Can J Neurol Sci"},{"key":"1608_CR32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00415-006-0198-8","volume":"253","author":"LR Pattison","year":"2006","unstructured":"Pattison LR, Kotter MR, Fraga D, Bonelli RM (2006) Apoptotic cascades as possible targets for inhibiting cell death in Huntington's disease. J Neurol 253:1137\u20131142","journal-title":"J Neurol"},{"key":"1608_CR33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","volume":"10","author":"J Kriz","year":"2002","unstructured":"Kriz J, Nguyen MD, Julien JP (2002) Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 10:268\u2013278","journal-title":"Neurobiol Dis"},{"key":"1608_CR34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","volume":"196","author":"HS Kim","year":"2009","unstructured":"Kim HS, Suh YH (2009) Minocycline and neurodegenerative diseases. Behav Brain Res 196:168\u2013179","journal-title":"Behav Brain Res"},{"key":"1608_CR35","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","volume":"100","author":"X Wang","year":"2003","unstructured":"Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci U S A 100:10483\u201310487","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1608_CR36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797\u2013801","journal-title":"Nat Med"},{"key":"1608_CR37","doi-asserted-by":"crossref","first-page":"19948","DOI":"10.1074\/jbc.M313629200","volume":"279","author":"J Wang","year":"2004","unstructured":"Wang J, Wei Q, Wang CY, Hill WD, Hess DC, Dong Z (2004) Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279:19948\u201319954","journal-title":"J Biol Chem"},{"key":"1608_CR38","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.21-08-02580.2001","volume":"21","author":"T Tikka","year":"2001","unstructured":"Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580\u20132588","journal-title":"J Neurosci"},{"key":"1608_CR39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/jnr.1104","volume":"64","author":"L Yuan","year":"2001","unstructured":"Yuan L, Neufeld AH (2001) Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 64:523\u2013532","journal-title":"J Neurosci Res"},{"key":"1608_CR40","first-page":"2962","volume":"43","author":"R Naskar","year":"2002","unstructured":"Naskar R, Wissing M, Thanos S (2002) Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest Ophthalmol Vis Sci 43:2962\u20132968","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1167\/iovs.03-0687","volume":"45","author":"BC Chauhan","year":"2004","unstructured":"Chauhan BC, LeVatte TL, Jollimore CA, Yu PK, Reitsamer HA, Kelly ME, Yu DY, Tremblay F, Archibald ML (2004) Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci 45:144\u2013152","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1608_CR42","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1167\/iovs.07-1337","volume":"49","author":"A Bosco","year":"2008","unstructured":"Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML (2008) Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA\/2\u00a0J mouse model of glaucoma. Invest Ophthalmol Vis Sci 49:1437\u20131446","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1608-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1608-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1608-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T19:48:06Z","timestamp":1559936886000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1608-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,13]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1608-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,13]]}}}